Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Infections × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Urinary Bladder Neoplasms 5 Leukemia, Myeloid, Acute 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Mouth Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Ureteral Neoplasms 2 Recurrence 2 Oropharyngeal Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Carcinoma 2 COVID-19 2 Brain Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tonsillar Neoplasms 1

Interventions

telavancin 1 monalizumab 1 fludarabine phosphate 1 fish oil triglycerides 1 avdoralimab 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Therapeutics 1 Tacrolimus 1 Standard of Care 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Observation 1 Methotrexate 1 Melphalan 1 Interferon-gamma 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Daptomycin 1 Cyclophosphamide 1 Clarithromycin 1 Caspofungin 1 Bevacizumab 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡